Pristine Surgical adds Chris Cleary to its Board of Directors

– USA, NH –  Pristine Surgical, a medical device company dedicated to simplifying endoscopy with its 4K single-use digital arthroscopes, announced the addition of Chris Cleary to its Board of Directors.

About Christopher Cleary

Chris Cleary recently served as SVP of Corporate Development for Medtronic, where he led acquisition and investment strategies, including the landmark $50 billion acquisition of Covidien in 2014.

Chris brings over two decades of experience in corporate development, mergers, and acquisitions, having significantly impacted the medical technology industry through his strategic leadership and visionary approach. He also facilitated over 35 acquisitions, and 25 investments, and orchestrated the $6 billion sale of Covidien’s medical supply assets to Cardinal Health. His strategic acumen and negotiation skills helped drive Medtronic’s growth and market expansion. Before joining Medtronic, Chris was the CEO of Alesia Capital Services. Before that, he had a significant tenure at GE Capital, where he held various senior leadership roles.

About Pristine Surgical

Pristine Surgical is a medical device company with a mission to simplify endoscopy. The company combines 4K single-use, digital arthroscopes with cloud-based software to make minimally invasive visualization more efficient, consistent, and safe. Pristine Surgical offers a subscription business model with transparent pricing and automated inventory management, delivering improved workflow and reduced costs to the endoscopy suite.

For more information: https://pristinesurgical.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.